AREV Life Sciences Global Corp
CNSX:AREV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AREV Life Sciences Global Corp
Revenue
AREV Life Sciences Global Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
AREV Life Sciences Global Corp
CNSX:AREV
|
Revenue
CA$49.1k
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Modern Plant Based Foods Inc
CNSX:MEAT
|
Revenue
CA$544.5k
|
CAGR 3-Years
-25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
BioNeutra Global Corp
XTSX:BGA
|
Revenue
CA$10.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Revenue
CA$822.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
P
|
Planet Based Foods Global Inc
CNSX:PBF
|
Revenue
$217.9k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Pangea Natural Foods Inc
CNSX:PNGA
|
Revenue
CA$12.2k
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AREV Life Sciences Global Corp
Glance View
AREV Life Sciences Global Corp. engages in the production and development of natural health and cannabis infused products. The company is headquartered in Coquitlam, British Columbia. The company went IPO on 2007-07-12. The firm focuses on delivering solutions to public healthcare metrics through collaborations in the life science industry. Its initial business is to produce and sell functional ingredients produced through its extraction systems. These ingredients and products are targeted at the natural health, medical, functional food, nutraceutical, sport nutrition markets. Its technologies enable the extraction of targeted essential and functional oils from target biomass, including hemp, create formulations combining cannabidiol (CBD) with these extracted oils or powders offered in various delivery methods, such as gel caps in branded formats for consumer markets. The company offers nutraceutical products, ready to use therapeutic food products (RUTF's) and therapeutic drug discovery. Its subsidiaries include AREV (Cambodia) Brands Co., Ltd. and AREV Life Sciences Inc.
See Also
What is AREV Life Sciences Global Corp's Revenue?
Revenue
49.1k
CAD
Based on the financial report for Dec 31, 2022, AREV Life Sciences Global Corp's Revenue amounts to 49.1k CAD.
What is AREV Life Sciences Global Corp's Revenue growth rate?
Revenue CAGR 3Y
-37%
Over the last year, the Revenue growth was -81%. The average annual Revenue growth rates for AREV Life Sciences Global Corp have been -37% over the past three years .
